NCT02871817|Unknown
A Comparison of the Checkup Vision Assessment System to Standard Vision Assessment Tools
CLEAR
The Correlation of the Checkup Vision Assessment System to Standard In Office Visual Assessment
Loading search results
CLEAR
The Correlation of the Checkup Vision Assessment System to Standard In Office Visual Assessment
Sponsor study identifier
observational
143
1 country
12
Study Start
July 2016
Actual (reported)Primary Completion
March 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The CLEAR study is testing the level of agreement between visual acuity and Amsler grid testing using a mobile vision testing application, Checkup Study, and standard in office methods. In addition the percent of patients able to successfully complete home testing on the digital device will be assessed.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2016
Actual (reported)July 18, 2016
Actual (reported)August 18, 2016
Actual (reported)March 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
March 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Near Corrected Visual Acuity
Corrected Near Visual Acuity (CNVA) assessed with the Checkup System will be compared to the reference method CNVA (Lebensohn Near Card) in replicated measurements at each of two in-office visits.
Eight weeks
Amsler Grid
The Amsler Grid assessment with the Checkup will be compared to the reference method Amsler Grid in replicated measurements at each of two in-office visits
Eight weeks
Feasibility of home testing using Paxos Checkup Mobile application
Eight weeks
Patients without significant vision deficit (20/20 vision), when eligible and providing informed consent, assigned to evaluation with Paxos Checkup Study Mobile Medical Application
Patients presenting with dry AMD or neovascular (wet) AMD, when eligible and providing informed consent, assigned to evaluation with Paxos Checkup Study Mobile Medical Application
Patients presenting with Diabetic Retinopathy, when eligible and providing informed consent, assigned to evaluation with Paxos Checkup Study Mobile Medical Application
The Digisight Paxos Checkup TM is mobile vision assessment system which consists of an application installed on a mobile device with an Internet connection, an Internet Cloud-based vision care network and a web site. The Paxos Checkup app contains a set of quantitative near vision tests, which a patient can take at home or elsewhere using an Internet capable mobile device.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Study population includes patients with no pathology, patients with Diabetic Retinopathy and patients with Adult Macular Degeneration.
Phoenix, Arizona, United States
Mountain View, California, United States
Fort Myers, Florida, United States
Miami, Florida, United States
Tallahassee, Florida, United States
Lexington, Kentucky, United States
Reno, Nevada, United States
Carol Hoang
Digisight Technologies, Inc.
143 participants (actual enrollment reported by the registry).
First Submitted
July 18, 2016
First Posted
August 18, 2016
Study Start
July 2016
Actual (reported)Village-Integrated Eye Worker Trial II
Assess repeatability of mobile application testing
8 weeks
Contact the study team to confirm eligibility.
Cleveland, Ohio, 44122, United States
Nashville, Tennessee, 37215, United States
Austin, Texas, United States
San Antonio, Texas, United States
Spokane, Washington, United States
Primary Completion
March 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
January 26, 2018
Record last verified: 2018-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: